Herrera CA, Eichelberger KY, Chescheir NC. Antiviral-resistant fulminant herpes hepatitis in pregnancy.
AJP Rep 2013;
3:87-90. [PMID:
24147242 PMCID:
PMC3799707 DOI:
10.1055/s-0033-1343791]
[Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/12/2013] [Accepted: 02/26/2013] [Indexed: 11/30/2022] Open
Abstract
Fulminant herpes hepatitis with disseminated extrahepatic involvement in pregnancy is rare and carries a high mortality risk. Although acyclovir remains standard first-line therapy, effective management of acyclovir-resistant disseminated herpes simplex virus (HSV) in pregnancy remains elusive. We present a case of disseminated HSV resistant to both acyclovir and foscarnet, the first double-agent resistant case in pregnancy reported in the literature to date. In this case, therapeutic delivery was the ultimate treatment resulting in full recovery.
Collapse